Infallible Pharma Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 2.44 Cr
as on 06-07-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.50 Cr
as on 06-07-2024
- Satisfied Charges ₹ 8.00 Cr
as on 06-07-2024
- Revenue -34.80%
(FY 2023)
- Profit -99.69%
(FY 2023)
- Ebitda -19.14%
(FY 2023)
- Net Worth -0.02%
(FY 2023)
- Total Assets 45.61%
(FY 2023)
About Infallible Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.44 Cr.
The company currently has active open charges totaling ₹22.50 Cr. The company has closed loans amounting to ₹8.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shreekant Shetty and Hari Om serve as directors at the Company.
- CIN/LLPIN
U24304MH2019PTC322834
- Company No.
322834
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2019
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Infallible Pharma Private Limited offer?
Infallible Pharma Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Injection, Common Disease Medicines, Injectable Products, Anti Infective Agent, Digestive System Drugs & Medicines, Antacid Drugs, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Cardiovascular Drugs & Medication.
Who are the key members and board of directors at Infallible Pharma?
Executive Team (1)
HO
Hari Om
Managing DirectorAppointment Date: 20-Mar-2019
Status: Current
Board Members(1)
Financial Performance and Corporate Structure Insights of Infallible Pharma.
Infallible Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.8% decrease. The company also saw a substantial fall in profitability, with a 99.69% decrease in profit. The company's net worth dipped by a decrease of 0.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Infallible Pharma?
In 2023, Infallible Pharma had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sagent Pharmaceuticals Private Limited
Active
1 year 5 months Shreekant Shetty and Hari Om are mutual person
Bsh Consultancy Private Limited
Active 6 years 8 months Shreekant Shetty and Hari Om are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Nov 2023 | ₹7.50 Cr | Open |
Others Creation Date: 26 Aug 2021 | ₹15.00 Cr | Open |
Others Creation Date: 27 Oct 2022 | ₹8.00 Cr | Satisfied |
How Many Employees Work at Infallible Pharma?
Infallible Pharma has a workforce of 69 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Sep 15, 2023, Infallible Pharma has raised a total of ₹ 10.02 Cr, with the most recent deal valued at ₹ 9 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
